IPR License extends STM reach

    IPR License, the global rights and licensing specialists, has extended its reach into the STM marketplace through the announcement of a partnership with global healthcare knowledge provider, BMJ.

    BMJ is looking to utilise the fully transactional rights and licensing marketplace TradeRights, IPR’s flagship product, to reach a wider international audience for its extensive collection of journal and book rights. It will join other major names in the STM field already showcasing key titles on TradeRights, including Elsevier, Wolters Kluwer, SAGE, Ashgate, Gower and Lund Humphries and Kogan Page.

    Since starting out as the publisher of a single medical journal in 1840, BMJ has developed a unique range of capabilities to meet today’s global healthcare challenges. The BMJ is now one of the world’s top four medical journals and publishes more than 50 of the world’s leading medical and allied science journals.

    IPR License is also in extensive discussions with a number of STM and academic publishing houses with deals expected to be signed at the upcoming Frankfurt Book Fair.

    Tom Chalmers, Managing Director of IPR License, commented:

    “It’s a real positive to see even more high profile names in the STM field realising the benefits attached to the TradeRights marketplace. This particular community has long realised the importance of licensing their works and have been quick to grasp the concept of automating these transactions whilst broadening their international reach. We look forward to working closely with BMJ to help create even more opportunities for them to enhance their rights and licensing business on a global scale.”

    Julie Halfacre, International Rights and Licensing Manager of BMJ, commented:

    “We look forward to working with IPR License. At BMJ our key objective is to support medical professionals and organisations in improving the delivery of high quality healthcare worldwide. Presence on the IPR platform will help BMJ to increase engagement with companies in various markets. Licensing our content allows repackaging to suit market needs: breaking down access barriers to the consumer such as language and cost.”


    For further information please visit www.iprlicense.com